Onderneming eFFECTOR Therapeutics, Inc.
Aandelen
EFTR
US28202V2079
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,89 USD | -5,03% | -19,92% | -83,83% |
Vakgebied
Aantal werknemers: 14
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Worland
CEO | Chief Executive Officer | 66 | 01-05-12 |
Michael Byrnes
DFI | Director of Finance/CFO | 47 | 01-12-20 |
Douglas Warner
CTO | Chief Tech/Sci/R&D Officer | 52 | 08-08-22 |
Mark Densel
PRN | Corporate Officer/Principal | - | 01-11-18 |
Mayank J. Gandhi
PRN | Corporate Officer/Principal | 47 | 26-09-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Worland
CEO | Chief Executive Officer | 66 | 01-05-12 |
Director/Board Member | 54 | 25-08-21 | |
Caroline Loewy
BRD | Director/Board Member | 58 | 11-09-23 |
Brian Gallagher
CHM | Chairman | 54 | 01-01-20 |
Barbara Klencke
BRD | Director/Board Member | 66 | 01-11-21 |
Elizabeth Bhatt
BRD | Director/Board Member | 56 | 25-08-21 |
Director/Board Member | 51 | 15-02-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 3 699 309 | 3 553 586 ( 96,06 %) | 12 000 ( 0,3244 %) | 96,06 % |
Bedrijfsgegevens
eFFECTOR Therapeutics, Inc.
142 North Cedros Avenue Suite B
92075, Solana Beach
+
http://www.effector.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-83,83% | 7,34 mln. | |
-3,39% | 102 mld. | |
+2,61% | 96,09 mld. | |
-1,02% | 22,05 mld. | |
-18,14% | 20,81 mld. | |
-6,87% | 19,06 mld. | |
-40,70% | 16,05 mld. | |
-26,89% | 14,01 mld. | |
+1,12% | 13,38 mld. | |
+22,25% | 11,01 mld. |
- Beurs
- Aandelen
- Koers EFTR
- Onderneming eFFECTOR Therapeutics, Inc.